SURFACE ONCOLOGY
SURFACE ONCOLOGY
Share · US86877M2098 · SURF · A2JJ8Q (LSSI)
Overview Financial Indicators
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - - - -2,12 % 0,06 % -75,51 %

Company Profile for SURFACE ONCOLOGY Share

Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibody that inhibits CD39 enzymatic activity for the production of adenosine and the breakdown of adenosine triphosphate; SRF388 targeting interleukin 27; GSK4381562, an antibody targeting CD112R, an inhibitory protein expressed on natural killer and T cells; and SRF114 targeting the chemokine receptor CCR8. Surface Oncology, Inc. has a license agreement with GlaxoSmithKline Intellectual Property (No. 4) Limited to develop, manufacture, and commercialize antibodies that targets SRF813; and license agreement with Vaccinex, Inc. to develop, manufacture, and commercialize antibodies, which targets SRF114. The company was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Invested Funds

The following funds have invested in: SURFACE ONCOLOGY invested:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
8,26
Percentage (%)
0,02 %

Company Data

Name SURFACE ONCOLOGY
Company Surface Oncology, Inc.
Symbol SURF
Website https://www.surfaceoncology.com
Primary Exchange LSSI Lang & Schwarz
WKN A2JJ8Q
ISIN US86877M2098
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Ms. Lisa McGrath
Market Capitalization 65 Mio
Country United States of America
Currency EUR
Employees 0,0 T
Address 50 Hampshire Street, 02139 Cambridge
IPO Date 2018-04-19

Ticker Symbols

Name Symbol
NASDAQ SURF

More Shares

Investors who SURFACE ONCOLOGY hold also have the following shares in their portfolio:
AMGEN INC
AMGEN INC Share
ANSYS INC
ANSYS INC Share
AUTODESK INC
AUTODESK INC Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
CX CORP
CX CORP Share
DAN.IN.SICAV-EUR.SM.CAP A
DAN.IN.SICAV-EUR.SM.CAP A Fund
INCYTE CORP
INCYTE CORP Share
INTEL CORP
INTEL CORP Share
MICROSOFT CORP
MICROSOFT CORP Share
MONDELEZ INTERNATIONAL INC - CLASS A
MONDELEZ INTERNATIONAL INC - CLASS A Share
ORANGE 21/UND. FLR MTN
ORANGE 21/UND. FLR MTN Bond
ROOT INC
ROOT INC Share
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025